Sorry, you need to enable JavaScript to visit this website.

Home > Departments > Rowan Medicine - Neuromusculoskeletal Institute > SNJMATCOE Training Series > OVERVIEW OF OFFICE BASED ADDICTION- LIVE IN-PERSON OR VIRTUAL


IN-PERSON DIDACTIC: Will be held on Wednesday, June 26, 2024 at 9am EDT. Registration is now open.


This is a hybrid live activity that will use a standardized, evidence-based substance use disorder (SUD) prevention, treatment, harm reduction, and recovery curriculum to train and inform New Jersey health care licensees with prescribing authority, in compliance with federal and state statutory and regulatory guidelines. This in-person didactic is designed to inform New Jersey health care professionals on a comprehensive overview of office-based addiction care from management of the most common substance use disorders (SUDs) to managing patient-directed discharge to harm reduction strategies.

TARGET AUDIENCE: Physicians; Physician Assistants (PAs); Certified Nurse Midwives (CNMs); Advanced Practice Nurses (APNs)

LEARNING OBJECTIVES: At the conclusion of this activity, participants will be able to:

1. Discuss the neurobiology of addiction, addiction cycle framework (binge/intoxication, withdrawal, and preoccupation/anticipation), and neuroadaptations in the domains of increased incentive salience, decreased brain reward and increased stress, and compromised executive function.

2. Identify the historical origins of the overdose crisis and influence of policy on its flaws and progressions, and discuss trends and statistics pertaining to medication for addiction treatment (MAT) and lack of access and barriers to utilization.

3. Recommend reasoning for screening, brief intervention, and referral for treatment (SBIRT) of patients with substance use disorder (SUD) in emergency medicine (EM) and inpatient care settings, and compare various screening methodologies for predicting aberrant substance-related behavior among patients receiving opioids for chronic pain management, and those using illicit fentanyl, heroin, and other substances.

4. Recognize chronic pain management strategies to minimize or avoid the use of opioids for pain management with a special focus on alternative pain therapies including Alternatives to Opiates (ALTO®) and adjunctive treatments to opioids for acute and chronic pain including osteopathic manipulative therapy (OMT).

5. Distinguish differences between the three Food and Drug Administration (FDA)-approved forms of medication for addiction treatment (MAT) for opioid use disorder (OUD), other forms of evidence-based treatment for other substance use disorders (SUD), and treatment decisions in emergency medicine (EM) and inpatient care settings guided by the effectiveness of modalities across the continuum of OUD and other SUD severity.

6. Implement integration of medication for addiction treatment (MAT) into emergency medicine (EM) and inpatient care setting clinical workflows, and articulate the influence of MAT guidelines and policies.

7. Integrate substance withdrawal management and stabilization in emergency medicine (EM) and inpatient care settings with focus on special populations including people who inject drugs (PWID), patients with co-occurring disorders (COD), pregnant people, adolescents and young adults (AYA), and older adults.

8. Demonstrate reasoning for increased patient access to psychiatric providers and behavioral health clinicians for co-occurring disorders (COD), and primary care providers (PCP) and infectious disease (ID) specialists for human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV) testing.

9. Identify the significance of harm reduction strategies and policies as a social and health care intervention for people who use drugs (PWUD) including people who inject drugs (PWID), with a special focus on lifesaving risk mitigation strategies including naloxone, fentanyl test strips (FTS), syringe services programs (SSP), and safer drug consumption services (SCS).

10. Develop best practices for teaching evidence-based and comprehensive addiction medicine curricula to medical students, residents, and fellows.


Available Continuing Medical Education (CME) Credits for Physicians:

Rowan–Virtua School of Osteopathic Medicine (Rowan–Virtua SOM) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

Rowan–Virtua SOM designates this activity  for a maximum of 8 AOA Category 1–A credit(s) and will report CME and specialty credits commensurate with the extent of the physician’s participation in the activity.

Rowan–Virtua School of Osteopathic Medicine (Rowan–Virtua SOM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Rowan–Virtua SOM designates this live activity for 8 AMA PRA Category 1 credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

To receive a certificate of completion, and CME certificate: All health care professionals must complete an Attestation Form, Outcome Survey and an Evaluation to receive a certificate of completion. Upon completion of these items, physicians will receive a CME certificate (AOA or AMA), other healthcare professionals will receive an AMA participation certificate.


For all technical support with registration, please contact the Rowan Online Marketplace Support Center at (856) 256-5560 during the hours of 8am to 4pm EST, or submit an email ticket here.

For all inquiries pertaining to the Course please contact Shelly Lluz Takach, MPH, Grants Coordinator, Cooper Center for Healing,

For regular training and education updates from the Southern NJ MAT Center of Excellence, please follow SNJMATCOE on Twitter, LinkedIn, and Instagram.

Location (Full Address): 
Cooper University Hospital, Cooper Conference Center, Room 105, Camden, NJ 08103
Registration Deadline: 
06/25/2024 - 4:00pm